In that purpose and as a representative example of targeted therapy, it has been demonstrated that the demethylase activity of UTX is essential for the maintenance of SCL/TAL1-positive T-ALL and not for other oncogenic subtypes [214]. The gene discussed is TAL1; the disease is acute lymphoblastic leukemia.